HomePASG • NASDAQ
add
Passage Bio Inc
Previous close
$0.30
Day range
$0.28 - $0.31
Year range
$0.26 - $1.39
Market cap
18.77M USD
Avg Volume
228.15K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 13.82M | -23.42% |
Net income | -15.40M | 7.82% |
Net profit margin | — | — |
Earnings per share | -0.25 | 16.67% |
EBITDA | -13.62M | 21.01% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 63.36M | -39.39% |
Total assets | 86.01M | -38.80% |
Total liabilities | 39.30M | 10.24% |
Total equity | 46.71M | — |
Shares outstanding | 62.15M | — |
Price to book | 0.40 | — |
Return on assets | -36.68% | — |
Return on capital | -43.59% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -15.40M | 7.82% |
Cash from operations | -13.85M | 26.85% |
Cash from investing | 39.63M | 56.95% |
Cash from financing | — | — |
Net change in cash | 25.78M | 71.16% |
Free cash flow | -11.18M | 12.51% |
About
Founded
2017
Headquarters
Website
Employees
60
